These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26902877)

  • 1. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma.
    Trudeau V; Larcher A; Sun M; Boehm K; Dell'Oglio P; Sosa J; Tian Z; Fossati N; Briganti A; Shariat SF; Karakiewicz PI
    World J Urol; 2016 Oct; 34(10):1429-36. PubMed ID: 26902877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.
    Nguyen DP; Vilaseca A; Vertosick EA; Corradi RB; Touijer KA; Benfante NE; Sjoberg DD; Russo P
    World J Urol; 2016 Apr; 34(4):539-44. PubMed ID: 26215750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
    Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
    Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.
    Eminaga O; Akbarov I; Wille S; Engelmann U
    Int Urol Nephrol; 2015 Oct; 47(10):1653-63. PubMed ID: 26329746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma.
    Incesu RB; Morra S; Scheipner L; Baudo A; Cano Garcia C; Barletta F; Assad A; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; Ahyai S; Longo N; Tilki D; Graefen M; Karakiewicz PI
    Ann Surg Oncol; 2024 Aug; 31(8):5457-5464. PubMed ID: 38773038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients.
    Alevizakos M; Gaitanidis A; Nasioudis D; Msaouel P; Appleman LJ
    Clin Genitourin Cancer; 2019 Jun; 17(3):e447-e453. PubMed ID: 30799129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
    Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
    Merrill MM; Wood CG; Tannir NM; Slack RS; Babaian KN; Jonasch E; Pagliaro LC; Compton Z; Tamboli P; Sircar K; Pisters LL; Matin SF; Karam JA
    Urol Oncol; 2015 Apr; 33(4):166.e21-9. PubMed ID: 25700975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
    May M; Cindolo L; Zigeuner R; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Wolff I; Feciche B; Fenske F; Pichler M; Schips L; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Waidelich R; Stief C; Sountoulides P; Brookman-May S; ;
    Urol Oncol; 2014 Nov; 32(8):1252-8. PubMed ID: 25129141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study.
    Marchioni M; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Primiceri G; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):488-496. PubMed ID: 29229582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era.
    Marchioni M; Bandini M; Pompe RS; Tian Z; Martel T; Kapoor A; Cindolo L; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    Int Urol Nephrol; 2017 Dec; 49(12):2143-2149. PubMed ID: 28932952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
    Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
    Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer.
    Larcher A; Trudeau V; Dell'Oglio P; Tian Z; Boehm K; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Urology; 2017 Apr; 102():130-137. PubMed ID: 27884597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unclassified renal cell carcinoma: impact on survival following nephrectomy.
    Crispen PL; Tabidian MR; Allmer C; Lohse CM; Breau RH; Blute ML; Cheville JC; Leibovich BC
    Urology; 2010 Sep; 76(3):580-6. PubMed ID: 20223503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.